Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase (Q31859925)

4 July 2017

title

Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase (English)

1 reference

4 July 2017

Lackey DB

1

1 reference

4 July 2017

Groziak MP

2

1 reference

4 July 2017

Sergeeva M

3

1 reference

4 July 2017

Beryt M

4

1 reference

4 July 2017

Boyer C

5

1 reference

4 July 2017

Stroud RM

6

1 reference

4 July 2017

Sayre P

7

1 reference

4 July 2017

Park JW

8

1 reference

4 July 2017

Johnston P

9

1 reference

4 July 2017

Slamon D

10

1 reference

4 July 2017

Shepard HM

11

1 reference

4 July 2017

Pegram M

12

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

4 July 2017

published in

Biochemical Pharmacology

1 reference

4 July 2017

volume

61

1 reference

4 July 2017

issue

2

1 reference

4 July 2017

page(s)

179-189

1 reference

Inhibition of mouse thymidylate synthase promoter activity by the wild-type p53 tumor suppressor protein

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Genetic instability as a consequence of inappropriate entry into and progression through S-phase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Thymidylate synthase and drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Regulation of p53 expression by thymidylate synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

The catalytic mechanism and structure of thymidylate synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Thymidylate synthase: structure, inhibition, and strained conformations during catalysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Crystal structure of human thymidylate synthase: a structural mechanism for guiding substrates into the active site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Synthesis and evaluation of some masked phosphate esters of the anti-herpesvirus drug 882C (netivudine) as potential antiviral agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

Isolation and characterization of a thymidylate synthase-deficient human colon tumor cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900542-6

10.1016/S0006-2952(00)00542-6

7 January 2021

Identifiers

DOI

1 reference

4 July 2017

1 reference